✦ LIBER ✦

130PD ERLOTINIB RELATED TOXICITY IN ELDERLY PATIENTS AFFECTED BY NON-SMALL CELL LUNG CANCER (NSCLC)

✍ Scribed by Palazzo, A.; Iacovelli, R.; Mazzoli, M.; Mancini, M.L.; Passaro, A.; Altavilla, A.; Conte, D.; Naso, G.; Cortesi, E.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

EGFR mutations in patients with non-smal

✍ S. Ricciardi; B. Tedesco; M.R. Migliorino; P. Graziano; A. Leone; M. Di Salvia; 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 63 KB

Erlotinib treatment results in patients

✍ Salajka, F.; Pešek, M.; Skřičková, J.; Zatloukal, P.; Koubková, L.; Grygárková, 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 60 KB

72 Gefitinib in patients affected by non

✍ Bearz, A.; Vaccher, E.; Simon, S.; Michele, S.; Massimiliano, B.; Umberto, T. 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 128 KB

Erlotinib in a previously treated advanc

✍ C. Gridelli; A. Rossi; P. Maione; C. Ferrara; F. Del Gaizo; D. Nicolella; C. Gue 📂 Article 📅 2006 🏛 Springer-Verlag 🌐 English ⚖ 91 KB

Safety and feasibility of radiotherapy t

✍ F. Fiorica; F. Cartei; S. Ursino; A. Stefanelli; Y. Zagatti; S. Berretta; S. Fig 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 403 KB

Gefitinib in the treatment of elderly pa

✍ Bearz, Alessandra; Fratino, Lucia; Spazzapan, Simon; Berretta, Massimiliano; Gia 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 103 KB